Frederiksberg C, Denmark

Tanja Bertelsen Jensen


 

Average Co-Inventor Count = 4.6

ph-index = 5

Forward Citations = 40(Granted Patents)


Location History:

  • Frederiksberg C, DK (2013 - 2016)
  • Copenhagen, DK (2019)

Company Filing History:


Years Active: 2013-2019

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Tanja Bertelsen Jensen: Pioneering Innovations in Vaccine Development

Introduction

Tanja Bertelsen Jensen is a prominent inventor based in Frederiksberg C, Denmark. With an impressive portfolio of eight patents, she has significantly contributed to the field of vaccine development, particularly focusing on hepatitis C virus (HCV) research. Her innovations have paved the way for novel vaccine candidates and advanced methods in virology.

Latest Patents

Tanja's latest patents include the development of methods for the production of a whole virus vaccine candidate stock. This invention relates to a whole virus vaccine candidate stock that can be utilized for vaccination purposes, as well as the creation of a novel high titer virus, which is essential for this technique. Additionally, she has contributed to the innovation with "JFH-1 based HCV cell culture systems for NS5A of genotypes 1-7." This patent highlights the development of hepatitis C virus recombinants expressing NS5A from various genotypes, with a focus on improving growth kinetics through adaptive mutations, which were discovered through reverse genetic studies.

Career Highlights

Throughout her career, Tanja Bertelsen Jensen has collaborated with esteemed institutions such as Hvidovre Hospital and Københavns Universitet. Her work in these entities emphasizes her commitment to advancing medical research and public health through innovative solutions in vaccine technology.

Collaborations

Tanja has had the opportunity to work alongside distinguished colleagues like Judith Margarete Gottwein and Jens Bukh. These collaborations have fostered a productive environment for research and innovation, further enhancing the impact of her work in the field.

Conclusion

As an inventive force in the realm of vaccine research, Tanja Bertelsen Jensen continues to make significant strides in understanding and combating viral infections. Her patents not only showcase her expertise but also reflect her dedication to improving global health through innovative methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…